FDA Clears Wearable Insulin Delivery Device Omnipod GO for Type-2 Diabetes
Drug Topics
APRIL 27, 2023
Insulet plans to commercialize the new product in the United States starting in 2024.
Thu.Apr 27, 2023
469 
Amazon sunsets Halo fitness wearable in the face of competitive, crowded market
Fierce Healthcare
APRIL 27, 2023
Amazon sunsets Halo fitness wearable in the face of competitive, crowded market hlandi Thu, 04/27/2023 - 10:28
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
How Understanding Risk Factors Can Help Patients With Chronic Diseases Quit Smoking
Drug Topics
APRIL 27, 2023
How much does education about the specific risks of smoking assist in smoking cessation?
How biopharma dealmaking kicked back into action
PharmaVoice
APRIL 27, 2023
Events over the last year, including Pfizer’s Seagen buy and AstraZeneca’s CinCor deal, have foreshadowed the comeback of biopharma M&A.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Health Care Spending Has Shot Back Up to Pre-Pandemic Levels
Drug Topics
APRIL 27, 2023
The average annual healthcare spending for people with employer-sponsored insurance spending increased from $5,630 in 2020 to $6,467 in 2021. After decreasing in 2020, per person healthcare spending increased 15%.
Pharma’s immunology field is full of blockbusters, and it’s just getting started
PharmaVoice
APRIL 27, 2023
From the "father" of the IL-23 pathway at Janssen to a big acquisition by Merck, the ultra-competitive immunology space is still growing with the pace of innovation.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Bipartisan bill revives efforts to expand FTC oversight to nonprofit hospitals
Fierce Healthcare
APRIL 27, 2023
Bipartisan bill revives efforts to expand FTC oversight to nonprofit hospitals aburky Thu, 04/27/2023 - 14:02
Study: Fecal Microbiota Transplantation Likely Leads to Large Increase in Resolution of Recurrent C. Difficile
Pharmacy Times
APRIL 27, 2023
Fecal microbiota transplantation may result in a slight reduction in serious adverse events, but the confidence intervals around the summary estimate were wide in immunocompetent adults with recurrent C. difficile infection.
Chutes & Ladders—Kaiser snatches up chief digital officer, Allina names COO
Fierce Healthcare
APRIL 27, 2023
Chutes & Ladders—Kaiser snatches up chief digital officer, Allina names COO aburky Thu, 04/27/2023 - 16:54
Sotatercept Improves Exercise Capacity in Individuals With Pulmonary Arterial Hypertension
Pharmacy Times
APRIL 27, 2023
The median change from baseline at week 24 in the 6-minute walk distance was 34.4 m in the sotatercept group and 1 m in the placebo group among patients with pulmonary arterial hypertension.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
HRG Future 50
Drug Store News
APRIL 27, 2023
These products set themselves apart on store shelves in 2022.
FDA Approves First Orally Administered Fecal Microbiota Product for Recurrent C. Diff
Pharmacy Times
APRIL 27, 2023
Through 8 weeks after treatment, C. difficile recurrence in SER-109-treated participants was lower compared to placebo-treated participants.
Show 1339: Harnessing the Power of the Vagus Nerve
The People's Pharmacy
APRIL 27, 2023
We have multiple nervous systems. You are probably aware of the nerves that help move your arms to throw a ball or move your legs to jump. No doubt you also know about the fight-or-flight response triggered by a fright. The oddly named sympathetic nervous system is in charge of that. Many of us don’t pay much attention to the parasympathetic nervous system.
Study Finds Strong Disconnect Regarding Use of Anticoagulation Medication Between Physician, Patient
Pharmacy Times
APRIL 27, 2023
Less than 20% of physicians were open to starting a patient with nonvalvular atrial fibrillation on an anticoagulant after conducting a clinical review of the patient’s care.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
A research team airs the messy truth about AI in medicine — and gives hospitals a guide to fix it
STAT
APRIL 27, 2023
In public, hospitals rave about artificial intelligence. They trumpet the technology in press releases, plaster its use on billboards, and sprinkle AI into speeches touting its ability to detect diseases earlier and make health care faster, better, and cheaper. But on the front lines, the hype is smashing into a starkly different reality.
Trial Shows Iptacopan Lowers Need for Blood Transfusion in Almost All Patients With Paroxysmal Nocturnal Hemoglobinuria
Pharmacy Times
APRIL 27, 2023
The APPOINT-PNH study showed that twice-daily LNP023 (Iptacopan) helped patients with paroxysmal nocturnal hemoglobinuria control intravascular hemolysis.
REX Awards 2023: Technology and Automation
Drug Store News
APRIL 27, 2023
April's awards feature leaders in the technology and automation industry.
Study: Pneumococcal Carriage Prevalence Is Higher Among Those With Contact to Children
Pharmacy Times
APRIL 27, 2023
Analysis focuses on couples in the greater New Haven area in Connecticut between October 2020 and August 2021.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Approaching Sustainability: Progress Toward Carbon-Neutrality in Life Sciences
ISPE
APRIL 27, 2023
Approaching Sustainability: Progress Toward Carbon-Neutrality in Life Sciences Trudy Patterson Thu, 04/27/2023 - 10:57 iSpeak Blog iSpeak Approaching Sustainability: Progress Toward Carbon-Neutrality in Life Sciences Gul Dusi 27 April 2023 Industries around the world are working to reach carbon neutrality. By reducing greenhouse gas emissions or removing carbon dioxide from the atmosphere, companies can effectively make up for the emissions they produce elsewhere.
EC announces EU pharma reform that cuts market exclusivity
Pharmaceutical Technology
APRIL 27, 2023
The European Commission’s (EC) long-anticipated pharma reform plans in the European Union have finally been unveiled , indicating a focus on improving access to medicines across the bloc while cutting down on market exclusivity. Described as the largest reform in over 20 years, the proposed revision touches on multiple topics ranging from unequal access to innovative medicines across the EU to new environmental protections.
To prevent preeclampsia, experts push for broader blood pressure testing at home
STAT
APRIL 27, 2023
Eleni Tsigas likens her first experience with preeclampsia to a plane crash. She was in the midst of what she thought was a healthy first pregnancy, with low risk for complications. But at 29 weeks, she was rushed to the emergency room with what she now knows are classic signs of preeclampsia: very high blood pressure, a pounding headache, nausea, blurred vision.
Quitting Lilly's obesity drug tirzepatide may be difficult for many patients, exec says
Fierce Pharma
APRIL 27, 2023
Quitting Lilly's obesity drug tirzepatide may be difficult for many patients, exec says kdunleavy Thu, 04/27/2023 - 15:08
Facing industry pushback, Joint Commission plans to introduce proposed sustainability measures as optional
Fierce Healthcare
APRIL 27, 2023
Facing industry pushback, Joint Commission plans to introduce proposed sustainability measures as optional agliadkovskaya Thu, 04/27/2023 - 14:43
Vast sequencing project begins to unlock human genome’s secrets — by deciphering other mammals’ DNA
STAT
APRIL 27, 2023
Despite decades of advancements in genomics, we still don’t know what most of our DNA does. But an ambitious international research collaboration is providing new answers about how genetics shapes human health and disease, with help from an unlikely source — a menagerie of mammals. The findings , reported in a set of 11 studies published on Thursday in the journal Science, come out of the Zoonomia Project, which compared the genomes of 240 mammalian species.
Bristol's multiple new launches won't stop it from scouting for M&A deals, CEO says
Fierce Pharma
APRIL 27, 2023
Bristol's multiple new launches won't stop it from scouting for M&A deals, CEO says aliu Thu, 04/27/2023 - 10:16
Giant, Flashfood save 6M pounds of food from landfills
Drug Store News
APRIL 27, 2023
The milestone was achieved in less than two years.
PCC 2023: ESG, New Turf for Compliance
PharmExec
APRIL 27, 2023
While ESG is still in the early stages for pharma, many companies are moving forward with a need for compliance.
Realising the potential of AAV gene therapies
European Pharmaceutical Review
APRIL 27, 2023
Through pre-clinical and clinical trial success, adeno-associated viral vectors (AAVs) have consistently demonstrated their effectiveness as a tool for gene delivery to treat a variety of human diseases. As we stand at the precipice of an era that truly embraces gene therapies, there are clearly still a number of challenges to overcome to fully realise the potential of innovative AAVs.
Infographic: Providers’ picks
Drug Store News
APRIL 27, 2023
What are the OTC products most recommended by pharmacy clinicians? Our new survey lists the top picks across 12 categories.
Vertex gains FDA approval for expanded use of CF drug Trikafta
Pharmaceutical Technology
APRIL 27, 2023
Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) to expand the use of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to treat cystic fibrosis (CF) in children aged between two and five years with certain mutations. The treatment is now indicated for CF patients with a minimum of one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, or with a mutation in the CFTR gene that responds to Trikafta based on in
Study: Consumers shop drug stores for grocery, household items as much as pharmacy
Drug Store News
APRIL 27, 2023
Drug stores are favored over grocery stores, mass retailers and online for pharmacy and medical needs (64%), per Acosta Group's Drug Store Channel Shopper Insights study.
Seres and Nestlé Health receive FDA approval for Vowst microbiome therapy
Pharmaceutical Technology
APRIL 27, 2023
Seres Therapeutics and Nestlé Health Science have received approval from the US Food and Drug Administration (FDA) for Vowst (faecal microbiota spores, live-brpk) for preventing the recurrence of C difficile infection (CDI) in adults. Vowst is an orally administered microbiota-based therapeutic, previously known as SER-109, and is indicated for the prevention of recurrence of CDI in people aged 18 years and above following an antibacterial treatment for recurrent CDI (rCDI).
EVisit acquires Bluestream Health to build out digital tools as hospitals double down on telehealth strategies
Fierce Healthcare
APRIL 27, 2023
EVisit acquires Bluestream Health to build out digital tools as hospitals double down on telehealth strategies hlandi Thu, 04/27/2023 - 12:03
Let's personalize your content